✦ LIBER ✦

Serum IL-6 (sIL-6) predicts overall survival in patients with metastatic breast cancer (MBC)

✍ Scribed by S. Junius; I. Benoy; R. Salgado; R. Weytjens; P. Van Dam; P. Huget; J. Lemmens; L. Dirix

Book ID: 117658572
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 181 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81209-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating interleukin-6 predicts survi

Circulating interleukin-6 predicts survival in patients with metastatic breast cancer

✍ Roberto Salgado; Sara Junius; Ina Benoy; Peter Van Dam; Peter Vermeulen; Eric Va 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 1 views

## Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by upregulating anti‐apoptotic and angiogenic proteins in tumour cells. In murine models it has been demonstra

Serum leptin level and waist-to-hip rati

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

✍ Mehmet Artac, Hakan Bozcuk, Aysel Kıyıcı, Orhan Onder Eren… 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 365 KB

Serum epidermal growth factor receptor/H

Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer

✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a

Plasma D-dimer levels, serum VEGF, b-FGF

Plasma D-dimer levels, serum VEGF, b-FGF and IL-6 in metastatic breast cancer (MBC): correlation with tumour load and response to therapy

✍ L. Dirix; R. Weytjens; R. Salgado; I. Benoy; P. Vermeulen; A. Prové; P. Van Dam; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Influence of age, performance status, ca

Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer

✍ C. F. Jehn, B. Flath, A. Strux, M. Krebs, K. Possinger, A. Pezzutto, D. Lüftner 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 265 KB

Serum levels of IL-6 and TNF-α correlate

Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer

✍ Michalaki, V; Syrigos, K; Charles, P; Waxman, J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB